PTP-1B has been shown by several groups to function as either a proto-oncogene or a tumor suppressor depending on its substrate which varies based on cell type and context; its expression is increased in human breast, ovarian and epithelial carcinomas, and it is decreased in oesophageal carcinomas [47], [50]–[52]. The gene discussed is PTPN1; the disease is carcinoma.